Literature DB >> 9237618

HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae.

I G Macreadie1, D R Thorburn, D M Kirby, L A Castelli, N L de Rozario, A A Azad.   

Abstract

The biological effects of the HIV-1 accessory protein, Vpr, have been studied in yeast expression systems. In our previous study [1], employing the pCUP1-vpr copper-inducible expression cassette, Vpr was shown to cause growth arrest and structural defects. In this study yeast constitutively expressing vpr, through elevated copy number and/or elevated transcription levels, displayed no growth arrest in fermentative growth conditions while Vpr was produced at much lower levels than in the inducible expression system. However, such cells were respiratory deficient and unable to utilise ethanol or glycerol as the sole carbon source. They exhibited gross mitochondrial dysfunction displayed in the loss of respiratory chain complex I, II, III, IV and citrate synthase activities. The effects on mitochondria required a C-terminal domain of Vpr that contains a conserved amino acid sequence motif HFRIGCRHSRIG. These results suggest that the widely observed phenomenon of 'Vpr-induced growth arrest' in human cells could be due to mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237618     DOI: 10.1016/s0014-5793(97)00542-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons.

Authors:  S C Piller; G D Ewart; D A Jans; P W Gage; G B Cox
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides.

Authors:  Slavena Vylkova; Xuewei S Li; Jennifer C Berner; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr.

Authors:  M Masuda; Y Nagai; N Oshima; K Tanaka; H Murakami; H Igarashi; H Okayama
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long-term non-progressors.

Authors:  S Moretti; S Marcellini; A Boschini; G Famularo; G Santini; E Alesse; S M Steinberg; M G Cifone; G Kroemer; C De Simone
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

5.  HIV-1 Vpr triggers mitochondrial destruction by impairing Mfn2-mediated ER-mitochondria interaction.

Authors:  Chih-Yang Huang; Shu-Fen Chiang; Tze-Yi Lin; Shiow-Her Chiou; Kuan-Chih Chow
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

6.  The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore.

Authors:  E Jacotot; L Ravagnan; M Loeffler; K F Ferri; H L Vieira; N Zamzami; P Costantini; S Druillennec; J Hoebeke; J P Briand; T Irinopoulou; E Daugas; S A Susin; D Cointe; Z H Xie; J C Reed; B P Roques; G Kroemer
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

7.  Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2.

Authors:  E Jacotot; K F Ferri; C El Hamel; C Brenner; S Druillennec; J Hoebeke; P Rustin; D Métivier; C Lenoir; M Geuskens; H L Vieira; M Loeffler; A S Belzacq; J P Briand; N Zamzami; L Edelman; Z H Xie; J C Reed; B P Roques; G Kroemer
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

Review 8.  Oxidative Stress during HIV Infection: Mechanisms and Consequences.

Authors:  Alexander V Ivanov; Vladimir T Valuev-Elliston; Olga N Ivanova; Sergey N Kochetkov; Elizaveta S Starodubova; Birke Bartosch; Maria G Isaguliants
Journal:  Oxid Med Cell Longev       Date:  2016-10-13       Impact factor: 6.543

Review 9.  The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.

Authors:  María Eugenia González
Journal:  Int J Mol Sci       Date:  2017-01-10       Impact factor: 5.923

10.  Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae.

Authors:  Xiao-Jian Yao; Nicole Rougeau; Ghislaine Duisit; Julie Lemay; Eric A Cohen
Journal:  Retrovirology       Date:  2004-08-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.